Johnson Financial Group Inc (Wisconsin)’s Charles River Laboratories CRL Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7	Closed	-$1.21K	–	845
2026 Q1	$1.21K	Hold	7	–	–	﹤0.01%	845
2025 Q4	$1.4K	Hold	7	–	–	﹤0.01%	862
2025 Q3	$1.1K	Buy	+7	New	+$1.11K	﹤0.01%	1001
2025 Q2	–	Sell	-445	Closed	-$67K	–	746
2025 Q1	$67K	Buy	+445	New	+$74.6K	﹤0.01%	564
2024 Q4	–	Sell	-948	Closed	-$187K	–	869
2024 Q3	$187K	Sell	948 -352	-27%	-$73.2K	0.01%	362
2024 Q2	$269K	Buy	1,300 +390	+43%	+$88.4K	0.01%	283
2024 Q1	$247K	Buy	+910	New	+$217K	0.01%	277
2023 Q4	–	Sell	-17	Closed	-$3.33K	–	940
2023 Q3	$3.33K	Sell	17 -35	-67%	-$7.19K	﹤0.01%	584
2023 Q2	$10.9K	Buy	52 +24	+86%	+$4.78K	﹤0.01%	534
2023 Q1	$5.65K	Sell	28 -2	-7%	-$453	﹤0.01%	550
2022 Q4	$6.54K	Hold	30	–	–	﹤0.01%	522
2022 Q3	$6K	Buy	+30	New	+$6.48K	﹤0.01%	522

Other funds holding CRL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s CRL Position: Q2 2026 in Review

Johnson Financial Group Inc (Wisconsin) sold out of Charles River Laboratories (CRL) in Q2 2026, closing a stake of 7 shares — an estimated $1.21K sold.

Johnson Financial Group Inc (Wisconsin) first reported a position in CRL in Q3 2022 and held it in 12 quarters. The position peaked at $269K in Q2 2024. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

Johnson Financial Group Inc (Wisconsin) reported no remaining Charles River Laboratories position as of Q2 2026 after selling out during the quarter.
Johnson Financial Group Inc (Wisconsin) sold 7 Charles River Laboratories shares in Q2 2026, an estimated $1.21K.
Johnson Financial Group Inc (Wisconsin) first reported a position in Charles River Laboratories in Q3 2022 and held it in 12 quarters.
Johnson Financial Group Inc (Wisconsin)'s Charles River Laboratories position peaked at $269K in Q2 2024.
563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2026, filed 10 Aug 2026.